drugset / Trial / NCT06058000
A Phase 2 Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic Dermatitis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to assess efficacy, safety, and pharmacokinetics (PK) of QLM3003 Ointment in participants with mild or moderate atopic dermatitis.
Timeline
- Start
- 2023-11-13
- Primary completion
- 2024-09-02
- Completion
- 2024-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | QLM3003 | Unknown | 1.5 % | Topical |
| Subject | QLM3003 | Unknown | 2 % | Topical |